420 with CNW – Connecticut Federal Court Rules in Favor of Employees Taking Medical Marijuana

A federal district court has ruled that a nursing home violated the anti-discriminatory act when it rescinded a job offer to a job seeker who declared that she consumes medical cannabis off-duty and tested positive for THC in a pre-employment drugs test. Medical cannabis is legal in Connecticut where the plaintiff lives and sought to be employed by the nursing home.

The case was filed by the plaintiff last year and judgment was delivered last month, more than a year later. The defendant had tried to get the case dismissed arguing that federal laws allowed them to deny users of a controlled substance employment.

However, the federal district court ruled that the defendant couldn’t cite the Controlled Substances Act since the laws of Connecticut granted protections to patients who had a qualifying condition and were consuming marijuana in accordance with the state laws.

The plaintiff’s request for legal fees and punitive damages was denied by the federal court since the Connecticut law (Palliative Use of Medical Marijuana or PUMA) under which she sued did not prescribe such remedies in its protections for patients on medical cannabis.

The ruling against Bride Brook Nursing and Rehabilitation Center comes at a time when courts had initially ruled against employees on matters of medical marijuana. It is the first time that a federal court is making a decision in favor of an employee.

Other state courts had made similar favorable rulings for employees against employers who took action against them for consuming medical marijuana.

The decision by the federal court isn’t binding on all the other courts, but one can be certain that this case will be a point of reference in any future litigation on similar matters.

In fact, Bride Brook Nursing and Rehabilitation Center can appeal against this decision in order to have it reversed.

The case law on medical marijuana is still scanty since so few states have decriminalized it while it remains illegal at the federal law.

It may therefore be premature for anyone to think that the legal tide is shifting in favor of employees. All the same, it is wise for employers to review their policies regarding marijuana testing as a precondition for employment since they may expose themselves to costly suits that may leave the reputation of the companies in question in tatters.

What can help all concerned is some form of middle ground to be reached between the states where marijuana is legal and the federal level where decriminalization hasn’t occurred as yet. This is certainly the wish of industry players like Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) who want to see a more uniform regulatory framework.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – FBI Data Shows Increased Marijuana Arrests in 2017

New data that has just been released by the U.S. Federal Bureau of Investigations (FBI) reveals that the marijuana arrests made in 2017 were more than those which were recorded in 2016. These statistics are surprising given the fact that, by the end of 2017, 28 states had legalized medical or recreational consumption of cannabis.

In total, 659,700 people were arrested on marijuana-related charges in 2017, while the figure for 2016 stood at 653,349 arrests.

The wave of cannabis legalization doesn’t seem to have had any impact upon the law enforcement community, especially at the federal level. This is creating a measure of confusion in the public, since daily dilemmas arise regarding the subject of cannabis.

An example of the confusion is the position of Los Angeles International Airport permitting travelers to carry marijuana while the federal transportation authorities at the same airport retain the right to detain anyone found in possession of cannabis.

The FBI data reflects the same mixed signals. For example, about 91 percent of all those arrests were for simple possession of cannabis. That is a high figure given that 20 percent of the American population lives in a state where some form of cannabis legalization exists.

To put this in context, someone was arrested somewhere in the U.S. for marijuana related issues every 48 seconds throughout 2017.

Activists are livid at these statistics, given that about 100 people die each day in the country due to opioid overdoses yet no death has been reported anywhere as a result of a cannabis overdose. Cannabis advocates wondered why the efforts and the meager resources of law enforcement agencies couldn’t be directed where the real danger lies.

To put this misallocation of resources differently, the FBI data shows that for each person who was arrested for murder there were 49 individuals arrested on a marijuana-related charge.

This overzealousness on the part of law enforcement flies counter to the growth in public opinion favoring the use of cannabis either for recreational or medical purposes. If the trend of arrests continues, voters may be compelled to pile pressure on their elected leaders to rein in the law enforcement arm of government, which seems oblivious to what is happening in the states where cannabis is legal. Global Payout, Inc. (OTC: GOHE) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) must be wishing that the unclear regulatory climate around cannabis settles quickly so that the industry can shape up for the good of all concerned.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – UCLA Team to Investigate the Painkilling Effects of Cannabis

The U.S. Centers for Disease Control and Prevention (CDC) reported that 42,000 Americans died from an overdose of opioids in 2016 alone. Meanwhile, the consumption of cannabis by members of the American public has been growing rapidly over the years. How are these two issues related to the planned research on cannabis?

Plenty of anecdotal evidence exists to support the claim that cannabis has painkilling abilities. Several scientific studies also point to the possibility of cannabis having painkilling effects. However, little reliable scientific information is available to support or disprove those claims.

That may no longer be the case if the proposed study by a team of researchers from the University of California Los Angeles (UCLA) is completed successfully.

The researchers would like to ascertain what combination of CBD and THC provides the highest degree of painkilling effects for opioid patients.

Dr. Jeffrey Chen is the Executive Director of the Cannabis Research Initiative, which came up with the idea of conducting this study.

The actual study was designed by a professor of psychiatry and pharmacology, Edythe London. She explained that the research isn’t intended to provide evidence for or against the cannabis industry. The study is a scientific undertaking to understand a substance that is reputed to have so many medicinal effects.

The double-blind, placebo-controlled clinical study seeks to shed some light on one particular claim, the claim that cannabis can help to ease the pain suffered by patients.

The success of the study in proving that cannabis can combat pain would provide a glimmer of hope that a solution may be at hand for the opioid crisis facing the nation. Such a solution is desperately wanted, given the fact that about 40 percent of the opioid overdose fatalities reported by the CDC in 2016 were connected to prescription opioids.

Dr. Chen points out that the scientific community needs to play catch up quickly so that more information can be available to the public about cannabis. This information could save people from falling for yet-to-be-substantiated claims by cannabis product manufacturers.

However, the researchers have a huge task to overcome two major obstacles before the study can commence.

First, cannabis is federally regarded as a schedule 1 controlled substance, “a substance without any medical value and has a high potential for addictiveness.” The researchers must convince the Food and Drug Administration (FDA), as well as the Drug Enforcement Agency (DEA), to grant them permission to proceed with the study. It isn’t clear how easy, or how quickly, such regulatory approval can be secured.

Secondly, the researchers must look for funding for their study. Some money has been secured from UCLA’s Semel Institute for Neuroscience and Human Behavior and from some private donors. Additional funding requests have been made to local and federal sources. Entities like Canopy Rivers Corporation (TSX: WEED) (NYSE: CGC) and FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) must be keeping their fingers crossed, hoping that the necessary funding and approval is obtained so that the debate on the painkilling effects of marijuana can be put to rest once and for all.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net